돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1296856생성일: 2026년 10월 23일

Astaxanthin → meso-Astaxanthin

https://huagongshe.com/ko/reaction/1296856

반응식

참여 물질

역할이름HCID투입량
반응물AstaxanthinHCID 5281224—
용매HeptaneHCID 8900—
생성물meso-AstaxanthinHCID 1235842292.5%

반응 단계

A total of 40 preparative injections were processed using 84 L of mobile phase. Thirty-six (36) L of effluent were collected among the five fractions. The preparative system was flushed with 100 mL of methylene chloride approximately every 6–8 injections or whenever the chromatographic separation deteriorated due to effects from mixing with mobile phase in the pump heads during the injection process. Purified materials were recovered by removing the solvents in a rotary evaporator protected from light to afford 25.4 g of 3R, 3′R ester, 47.8 g of meso-(3R, 3′S) ester, and 24.9 g of 3S, 3′S ester. The purified astaxanthin dicamphanate esters were saponified to afford 8.5 g (79.8% purity by HPLC) of 3R, 3′R-astaxanthin, 18.2 g (90.1% purity by HPLC) of meso-astaxanthin, and 9.4 g (82.0% purity by HPLC) of 3S, 3′S-astaxanthin. The major impurities of the saponification reaction were the 13- and 9-cis isomers of astaxanthin, identified by HPLC. The cis-isomers were thermally isomerized to all-trans by refluxing in heptane to afford 8.5 g (87.3% purity by HPLC) of 3R, 3′R-astaxanthin, 18.2 g (92.5% purity by HPLC) of meso-astaxanthin, and 9.4 g (86.8% purity by HPLC) of 3S, 3′S-astaxanthin.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US07247752B2
출처 데이터셋uspto-grants-2007_07
ORD IDord-4653d60d58d44998a576491c7556f59b
출처 메모uspto-grants-2007_07